Inherited Cancer Syndrome

2

Review clinical trials related to Inherited Cancer Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

Pheochromocytomas and paragangliomas are neural crest-derived tumors of the nervous system that are often inherited and genetically heterogeneous. Genetic screening is recommended for patients and their relatives, and can guide clinical decisions. However, a mutation is not found in all cases. The aims of this proposal are to: 1) to map gene(s) involved in pheochromocytoma, and 2) identify genotype-phenotype correlations in patients with pheochromocytoma/paraganglioma of various genetic origins.

Participants needed: 2,000
Trial details
Biological sex: AllType: ObservationalSponsor: The University of Texas Health Science Center at San AntonioUpdated: Oct 15, 2025Locations: 1Duration: 30 Years
Eligibility criteria

diagnosis of pheochromocytoma and or paraganglioma [+3]

unconfirmed diagnosis of pheochromocytoma and/or paraganglioma or associated con...

Status: Recruiting

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program (SDS-GPS) is an opportunity for patients and their families - from anywhere in the world - to share their experience living with SDS via a safe, secure, and convenient online platform, to * expand the understanding of SDS * improve the lives of people with SDS, and * accelerate the development of new therapies and cures for SDS. By joining, participants will receive early access to relevant information about new clinical trials and other research opportunities (such as clinical registries) based on their profile, accelerating research and increasing clinical trial impact and recruitment success. The platform, consent forms, and surveys are available in five languages: English, Spanish, French, German, and Italian. More languages to come.

Participants needed: 8,000
Trial details
Biological sex: AllType: ObservationalSponsor: Shwachman-Diamond Syndrome Alliance IncUpdated: May 31, 2025Locations: 1Duration: 120 Years
Eligibility criteria

Patients with a confirmed Shwachman-Diamond Syndrome (SDS) diagnosis, including... [+3]